US Drug Recall Register

FDA Drug Recalls

1,739 recalls · Class I, newest first

Class I · High risk Terminated

Meizitang Strong Version Botanical Slimming

Reason Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: N-desmethylsibutramine, benzylsibutramine, and sibutramine

MyNicNaxs, Inc. D-1380-2014
Class I · High risk Terminated

Magic Slim capsules

Reason Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: N-desmethylsibutramine, benzylsibutramine, and sibutramine

MyNicNaxs, Inc. D-1379-2014
Class I · High risk Terminated

Slim Xtreme Weight loss capsules

Reason Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: N-desmethylsibutramine, benzylsibutramine, and sibutramine

MyNicNaxs, Inc. D-1378-2014
Class I · High risk Terminated

Meizi Evolution Soft Gel Capsules

Reason Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: N-desmethylsibutramine, benzylsibutramine, and sibutramine

MyNicNaxs, Inc. D-1377-2014
Class I · High risk Terminated

SlimEasy Herbs Capsule

Reason Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: sibutramine and N-desmethylsibutramine

MyNicNaxs, Inc. D-1376-2014
Class I · High risk Terminated

Pill for weight reduction

Reason Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: Phenolphthalein

MyNicNaxs, Inc. D-1375-2014
Class I · High risk Terminated

Super Fat Burning Bomb Capsules

Reason Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: Phenolphthalein and N-desmethylsibutramine

MyNicNaxs, Inc. D-1374-2014
Class I · High risk Terminated

Fruta BIO 400 mg capsules

Reason Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: Sibutramine and Phenolphthalein .

MyNicNaxs, Inc. D-1373-2014
Class I · High risk Terminated

JIANFEIJINDAN Activity Girl Capsules

Reason Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared ingredient: N-di-desmethylsibutramine, an analog of sibutramine

MyNicNaxs, Inc. D-1372-2014
Class I · High risk Terminated

REDUCE WEIGHT FRUTA PLANTA Capsules

Reason Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: Phenolphthalein.

MyNicNaxs, Inc. D-1371-2014
Class I · High risk Terminated

PRO ArthMax Dietary Supplement tablets

Reason Marketed without an Approved NDA/ANDA; FDA analysis found the product to contain Chlorzoxazone, Nefopam, Diclofenac, Ibuprofen, Naproxen, and Indomethacin

Human Science Foundation D-1327-2014
Class I · High risk Terminated

DOBUTamine Injection

Reason Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution.

Hospira Inc. NDC 0409-2344-02 D-1540-2014
Class I · High risk Terminated

Xzen Platinum

Reason Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

Schindele Enterprises dba Midwest Wholesale D-1340-2014
Class I · High risk Terminated

ExtenZe 600 mg

Reason Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

Schindele Enterprises dba Midwest Wholesale D-1339-2014
Class I · High risk Terminated

Magic For Men

Reason Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

Schindele Enterprises dba Midwest Wholesale D-1338-2014
Class I · High risk Terminated

MiracleZEN Platinum

Reason Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

Schindele Enterprises dba Midwest Wholesale D-1337-2014
Class I · High risk Terminated

Sexy Monkey

Reason Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

Schindele Enterprises dba Midwest Wholesale D-1336-2014
Class I · High risk Terminated

Boost Ultra

Reason Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

Schindele Enterprises dba Midwest Wholesale D-1335-2014
Class I · High risk Terminated

Xzone Gold

Reason Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

Schindele Enterprises dba Midwest Wholesale D-1334-2014
Class I · High risk Terminated

Burn 7 Capsules

Reason Marketed Without an Approved NDA/ANDA: Undeclared sibutramine and phenolphthalein in Burn 7 dietary supplement

Deseo Rebajar D-1351-2014
Class I · High risk Terminated

Lidocaine HCl Injection

Reason Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.

Hospira Inc. NDC 0409-2066-05 D-1278-2014
Class I · High risk Terminated

MINERAL IV Injection

Reason Non-Sterility; analytical results found product to contain Sphingomonas paucimobilis

Abrams Royal Pharamacy D-1563-2014
Class I · High risk Terminated

Calcium Gluconate 10% for Injection

Reason Non-Sterility: RX Formulation initiated this recall due to a report of microbial contamination found in Calcium Gluconate saturated solution that was observed upon drawing the vial contents into a syringe.

Zions RX Formulations Services LLC dba RX Formuations Serv. D-1213-2014
Class I · High risk Terminated

Dream Body Slimming Capsule

Reason Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and . Sibutramine is not currently marketed in the United States, making this product an unapproved new drug.

Slim Beauty USA D-1222-2014